These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 31576455)
1. Susceptibility of protein therapeutics to spontaneous chemical modifications by oxidation, cyclization, and elimination reactions. Grassi L; Cabrele C Amino Acids; 2019 Nov; 51(10-12):1409-1431. PubMed ID: 31576455 [TBL] [Abstract][Full Text] [Related]
2. THE PERIODATE OXIDATION OF AMINO ACIDS WITH REFERENCE TO STUDIES ON GLYCOPROTEINS. CLAMP JR; HOUGH L Biochem J; 1965 Jan; 94(1):17-24. PubMed ID: 14342227 [TBL] [Abstract][Full Text] [Related]
3. Post-translational modifications of recombinant proteins: significance for biopharmaceuticals. Jenkins N; Murphy L; Tyther R Mol Biotechnol; 2008 Jun; 39(2):113-8. PubMed ID: 18327554 [TBL] [Abstract][Full Text] [Related]
4. Radiolytic modification of sulfur-containing amino acid residues in model peptides: fundamental studies for protein footprinting. Xu G; Chance MR Anal Chem; 2005 Apr; 77(8):2437-49. PubMed ID: 15828779 [TBL] [Abstract][Full Text] [Related]
5. Determination of the origin of the N-terminal pyro-glutamate variation in monoclonal antibodies using model peptides. Dick LW; Kim C; Qiu D; Cheng KC Biotechnol Bioeng; 2007 Jun; 97(3):544-53. PubMed ID: 17099914 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of monoclonal antibodies. Liu H; Gaza-Bulseco G; Faldu D; Chumsae C; Sun J J Pharm Sci; 2008 Jul; 97(7):2426-47. PubMed ID: 17828757 [TBL] [Abstract][Full Text] [Related]
7. Understanding the conformational impact of chemical modifications on monoclonal antibodies with diverse sequence variation using hydrogen/deuterium exchange mass spectrometry and structural modeling. Zhang A; Hu P; MacGregor P; Xue Y; Fan H; Suchecki P; Olszewski L; Liu A Anal Chem; 2014 Apr; 86(7):3468-75. PubMed ID: 24597564 [TBL] [Abstract][Full Text] [Related]
8. Oxidation in the complementarity-determining regions differentially influences the properties of therapeutic antibodies. Dashivets T; Stracke J; Dengl S; Knaupp A; Pollmann J; Buchner J; Schlothauer T MAbs; 2016; 8(8):1525-1535. PubMed ID: 27612038 [TBL] [Abstract][Full Text] [Related]
9. Application of electrospray and fast atom bombardment mass spectrometry to the identification of post-translational and other chemical modifications of proteins and peptides. Kouach M; Belaïche D; Jaquinod M; Couppez M; Kmiecik D; Ricart G; Van Dorsselaer A; Sautière P; Briand G Biol Mass Spectrom; 1994 May; 23(5):283-94. PubMed ID: 8204685 [TBL] [Abstract][Full Text] [Related]
10. Oxidation of therapeutic proteins and peptides: structural and biological consequences. Torosantucci R; Schöneich C; Jiskoot W Pharm Res; 2014 Mar; 31(3):541-53. PubMed ID: 24065593 [TBL] [Abstract][Full Text] [Related]
11. Investigation of N-terminal glutamate cyclization of recombinant monoclonal antibody in formulation development. Yu L; Vizel A; Huff MB; Young M; Remmele RL; He B J Pharm Biomed Anal; 2006 Oct; 42(4):455-63. PubMed ID: 16828250 [TBL] [Abstract][Full Text] [Related]
12. Isomerization and Oxidation in the Complementarity-Determining Regions of a Monoclonal Antibody: A Study of the Modification-Structure-Function Correlations by Hydrogen-Deuterium Exchange Mass Spectrometry. Yan Y; Wei H; Fu Y; Jusuf S; Zeng M; Ludwig R; Krystek SR; Chen G; Tao L; Das TK Anal Chem; 2016 Feb; 88(4):2041-50. PubMed ID: 26824491 [TBL] [Abstract][Full Text] [Related]
14. Identification of N-terminal modification for recombinant monoclonal antibody light chain using partial reduction and quadrupole time-of-flight mass spectrometry. Yu L; Remmele RL; He B Rapid Commun Mass Spectrom; 2006; 20(24):3674-80. PubMed ID: 17117408 [TBL] [Abstract][Full Text] [Related]
15. Selective Oxidation of Methionine and Tryptophan Residues in a Therapeutic IgG1 Molecule. Folzer E; Diepold K; Bomans K; Finkler C; Schmidt R; Bulau P; Huwyler J; Mahler HC; Koulov AV J Pharm Sci; 2015 Sep; 104(9):2824-31. PubMed ID: 26010344 [TBL] [Abstract][Full Text] [Related]
16. Method to convert N-terminal glutamine to pyroglutamate for characterization of recombinant monoclonal antibodies. Xu W; Peng Y; Wang F; Paporello B; Richardson D; Liu H Anal Biochem; 2013 May; 436(1):10-2. PubMed ID: 23357233 [TBL] [Abstract][Full Text] [Related]
18. A novel method for in silico assessment of Methionine oxidation risk in monoclonal antibodies: Improvement over the 2-shell model. Tavella D; Ouellette DR; Garofalo R; Zhu K; Xu J; Oloo EO; Negron C; Ihnat PM PLoS One; 2022; 17(12):e0279689. PubMed ID: 36580468 [TBL] [Abstract][Full Text] [Related]
19. Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterization. Sandra K; Vandenheede I; Sandra P J Chromatogr A; 2014 Mar; 1335():81-103. PubMed ID: 24365115 [TBL] [Abstract][Full Text] [Related]
20. New cyclization reaction at the amino terminus of peptides and proteins. Rose K; Chen J; Dragovic M; Zeng W; Jeannerat D; Kamalaprija P; Burger U Bioconjug Chem; 1999; 10(6):1038-43. PubMed ID: 10563773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]